project id: TCGA-STAD; case submitter id: TCGA-BR-A4J8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 7.0; age at index: 71; days to birth: -26048; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 26048; ajcc pathologic m: M0; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 411.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 79; days to sample procurement: 0; initial weight: 730.0; portion submitter id: TCGA-BR-A4J8-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 70.0; percent tumor cells: 26.0; percent tumor nuclei: 70.0;